Favorable prognosis of brain metastases in small cell lung cancer

L. Giannone, D. H. Johnson, K. R. Hande, F. A. Greco

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Brain metastases are found at diagnosis in 10% of patients with small cell lung cancer. To clarify the effect of central nervous system metastases on prognosis, the records of 429 patients with small cell lung cancer were reviewed. Forty-three patients (10%) presented with brain metastases. In 18 patients the brain was the only site of metastatic disease, whereas the remaining 25 patients had at least one additional metastatic site. Forty-one of forty-three patients were treated with combination chemotherapy and cranial radiotherapy. Systemic response rates were similar for both groups. Twenty-seven patients underwent repeat central nervous system staging: 19 (70%) had a complete response, 4 (15%) a partial response, and 4 (15%) no response. Median survival of patients with only one site of metastatic disease was 11 months; patients with additional sites lived 5 months (p = 0.153). Survival in patients with only one site is similar to that in patients with limited disease (11 compared with 13 months; p = 0.074).

Original languageEnglish (US)
Pages (from-to)386-389
Number of pages4
JournalAnnals of Internal Medicine
Volume106
Issue number3
StatePublished - 1987

Fingerprint

Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
Central Nervous System
Survival
Combination Drug Therapy
Radiotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Giannone, L., Johnson, D. H., Hande, K. R., & Greco, F. A. (1987). Favorable prognosis of brain metastases in small cell lung cancer. Annals of Internal Medicine, 106(3), 386-389.

Favorable prognosis of brain metastases in small cell lung cancer. / Giannone, L.; Johnson, D. H.; Hande, K. R.; Greco, F. A.

In: Annals of Internal Medicine, Vol. 106, No. 3, 1987, p. 386-389.

Research output: Contribution to journalArticle

Giannone, L, Johnson, DH, Hande, KR & Greco, FA 1987, 'Favorable prognosis of brain metastases in small cell lung cancer', Annals of Internal Medicine, vol. 106, no. 3, pp. 386-389.
Giannone, L. ; Johnson, D. H. ; Hande, K. R. ; Greco, F. A. / Favorable prognosis of brain metastases in small cell lung cancer. In: Annals of Internal Medicine. 1987 ; Vol. 106, No. 3. pp. 386-389.
@article{7ca3c736662d4c74b9b5400bd0cd0c9a,
title = "Favorable prognosis of brain metastases in small cell lung cancer",
abstract = "Brain metastases are found at diagnosis in 10{\%} of patients with small cell lung cancer. To clarify the effect of central nervous system metastases on prognosis, the records of 429 patients with small cell lung cancer were reviewed. Forty-three patients (10{\%}) presented with brain metastases. In 18 patients the brain was the only site of metastatic disease, whereas the remaining 25 patients had at least one additional metastatic site. Forty-one of forty-three patients were treated with combination chemotherapy and cranial radiotherapy. Systemic response rates were similar for both groups. Twenty-seven patients underwent repeat central nervous system staging: 19 (70{\%}) had a complete response, 4 (15{\%}) a partial response, and 4 (15{\%}) no response. Median survival of patients with only one site of metastatic disease was 11 months; patients with additional sites lived 5 months (p = 0.153). Survival in patients with only one site is similar to that in patients with limited disease (11 compared with 13 months; p = 0.074).",
author = "L. Giannone and Johnson, {D. H.} and Hande, {K. R.} and Greco, {F. A.}",
year = "1987",
language = "English (US)",
volume = "106",
pages = "386--389",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "3",

}

TY - JOUR

T1 - Favorable prognosis of brain metastases in small cell lung cancer

AU - Giannone, L.

AU - Johnson, D. H.

AU - Hande, K. R.

AU - Greco, F. A.

PY - 1987

Y1 - 1987

N2 - Brain metastases are found at diagnosis in 10% of patients with small cell lung cancer. To clarify the effect of central nervous system metastases on prognosis, the records of 429 patients with small cell lung cancer were reviewed. Forty-three patients (10%) presented with brain metastases. In 18 patients the brain was the only site of metastatic disease, whereas the remaining 25 patients had at least one additional metastatic site. Forty-one of forty-three patients were treated with combination chemotherapy and cranial radiotherapy. Systemic response rates were similar for both groups. Twenty-seven patients underwent repeat central nervous system staging: 19 (70%) had a complete response, 4 (15%) a partial response, and 4 (15%) no response. Median survival of patients with only one site of metastatic disease was 11 months; patients with additional sites lived 5 months (p = 0.153). Survival in patients with only one site is similar to that in patients with limited disease (11 compared with 13 months; p = 0.074).

AB - Brain metastases are found at diagnosis in 10% of patients with small cell lung cancer. To clarify the effect of central nervous system metastases on prognosis, the records of 429 patients with small cell lung cancer were reviewed. Forty-three patients (10%) presented with brain metastases. In 18 patients the brain was the only site of metastatic disease, whereas the remaining 25 patients had at least one additional metastatic site. Forty-one of forty-three patients were treated with combination chemotherapy and cranial radiotherapy. Systemic response rates were similar for both groups. Twenty-seven patients underwent repeat central nervous system staging: 19 (70%) had a complete response, 4 (15%) a partial response, and 4 (15%) no response. Median survival of patients with only one site of metastatic disease was 11 months; patients with additional sites lived 5 months (p = 0.153). Survival in patients with only one site is similar to that in patients with limited disease (11 compared with 13 months; p = 0.074).

UR - http://www.scopus.com/inward/record.url?scp=0023105662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023105662&partnerID=8YFLogxK

M3 - Article

C2 - 3028222

AN - SCOPUS:0023105662

VL - 106

SP - 386

EP - 389

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 3

ER -